These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1911712

  • 1. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.
    Mao SJ, Yates MT, Parker RA, Chi EM, Jackson RL.
    Arterioscler Thromb; 1991; 11(5):1266-75. PubMed ID: 1911712
    [Abstract] [Full Text] [Related]

  • 2. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
    Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C.
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5928-31. PubMed ID: 3475709
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of probucol in reducing plasma low-density lipoprotein cholesterol oxidation in hypercholesterolemia.
    Masana L, Bargalló MT, Plana N, LaVille A, Casals I, Solà R.
    Am J Cardiol; 1991 Oct 01; 68(9):863-7. PubMed ID: 1927944
    [Abstract] [Full Text] [Related]

  • 4. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Kleinveld HA, Demacker PN, Stalenhoef AF.
    Arterioscler Thromb; 1994 Aug 01; 14(8):1386-91. PubMed ID: 8049202
    [Abstract] [Full Text] [Related]

  • 5. A water-extract of the Korean traditional formulation Geiji-Bokryung-Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits.
    Kim BJ, Kim YK, Park WH, Ko JH, Lee YC, Kim CH.
    Int Immunopharmacol; 2003 May 01; 3(5):723-34. PubMed ID: 12757741
    [Abstract] [Full Text] [Related]

  • 6. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
    Feldman DL, Mogelesky TC, Sharif R, Sawyer WK, Jeune M, Hu CW, Leonards KS, Prescott MF.
    Atherosclerosis; 1999 Jun 01; 144(2):343-55. PubMed ID: 10407495
    [Abstract] [Full Text] [Related]

  • 7. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits.
    Mao SJ, Yates MT, Rechtin AE, Jackson RL, Van Sickle WA.
    J Med Chem; 1991 Jan 01; 34(1):298-302. PubMed ID: 1992130
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.
    Andersen HO, Holm P, Nordestgaard BG, Hansen BF, Kjeldsen K, Elinder LS, Stender S.
    J Mol Cell Cardiol; 1995 Aug 01; 27(8):1561-71. PubMed ID: 8523419
    [Abstract] [Full Text] [Related]

  • 10. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits.
    Daugherty A, Zweifel BS, Schonfeld G.
    Br J Pharmacol; 1991 May 01; 103(1):1013-8. PubMed ID: 1878742
    [Abstract] [Full Text] [Related]

  • 11. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza.
    Wu YJ, Hong CY, Lin SJ, Wu P, Shiao MS.
    Arterioscler Thromb Vasc Biol; 1998 Mar 01; 18(3):481-6. PubMed ID: 9514418
    [Abstract] [Full Text] [Related]

  • 12. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
    Ou J, Saku K, Jimi S, Liao YL, Ohta T, Zhang B, Arakawa K.
    Jpn Circ J; 1999 Jun 01; 63(6):471-7. PubMed ID: 10406588
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
    Lauridsen ST, Mortensen A.
    Atherosclerosis; 1999 Jan 01; 142(1):169-78. PubMed ID: 9920518
    [Abstract] [Full Text] [Related]

  • 15. Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.
    Niimi M, Keyamura Y, Nozako M, Koyama T, Kohashi M, Yasufuku R, Yoshikawa T, Fan J.
    Lipids Health Dis; 2013 Nov 04; 12():166. PubMed ID: 24188322
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits.
    Yoshida N, Murase H, Kunieda T, Toyokuni S, Tanaka T, Terao J, Naito Y, Tanigawa T, Yoshikawa T.
    Atherosclerosis; 2002 May 04; 162(1):111-7. PubMed ID: 11947904
    [Abstract] [Full Text] [Related]

  • 17. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Carew TE, Schwenke DC, Steinberg D.
    Proc Natl Acad Sci U S A; 1987 Nov 04; 84(21):7725-9. PubMed ID: 3478721
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dual effects of the antioxidant agents probucol and carvedilol on proliferative and fatty lesions in hypercholesterolemic rabbits.
    Donetti E, Soma MR, Barberi L, Paoletti R, Fumagalli R, Roma P, Catapano AL.
    Atherosclerosis; 1998 Nov 04; 141(1):45-51. PubMed ID: 9863537
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.